3CC | Third Culture Capital

3CC | Third Culture Capital is a Boston-based venture capital firm that focuses on early-stage investments at the intersection of healthcare, human capital, and financial capital. Founded with a mission to drive diversity, innovation, and equity in healthcare, 3CC invests in startups that bring together cross-cultural and cross-disciplinary approaches to healthcare innovation. The firm’s unique name, "Third Culture," reflects its commitment to supporting entrepreneurs with diverse backgrounds who are poised to disrupt traditional healthcare models. 3CC’s investment strategy targets innovations that can improve patient outcomes, reduce costs, and enhance the overall experience of care for both patients and providers. The firm typically makes investments ranging from $250,000 to $1 million, and prefers to lead funding rounds, providing not just capital but also strategic support through its extensive network of healthcare professionals. 3CC’s portfolio includes companies that are making significant strides in various healthcare sectors, such as Ciba Health, Voiceitt, and Pragma Bio, each focused on leveraging technology to solve critical healthcare challenges. The firm is deeply committed to fostering a more inclusive and innovative healthcare industry by lowering barriers to entry for underrepresented entrepreneurs and promoting collaborative decision-making.